Prediction of Methotrexate Intolerance in Juvenile Idiopathic Arthritis: a prospective, observational cohort study

被引：0
作者：
Evert Hendrik Pieter van Dijkhuizen
Maja Bulatović Ćalasan
Saskia MF Pluijm
Maurits CFJ de Rotte
Sebastiaan J Vastert
Sylvia Kamphuis
Robert de Jonge
Nico M Wulffraat
机构：
[1] University Medical Centre Utrecht,Department of Paediatric Immunology
[2] Wilhelmina Children’s Hospital,Department of Paediatric Haemato
[3] Erasmus University Medical Centre Rotterdam,Oncology
[4] Sophia Children’s Hospital,Department of Clinical Chemistry
[5] Erasmus University Medical Centre Rotterdam,Department of Paediatric Rheumatology
[6] Erasmus University Medical Centre Rotterdam,undefined
[7] Sophia Children’s Hospital,undefined
[8] Pediatria II,undefined
[9] Reumatologia,undefined
[10] IRCCS G. Gaslini,undefined
来源：
Pediatric Rheumatology | / 13卷
关键词：
Juvenile idiopathic arthritis; Methotrexate; Adverse events; Methotrexate intolerance; Prediction model; Predictor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Perceptions of Methotrexate Intolerance and Its Impact on Daily Life in School-Age Children with Juvenile Idiopathic Arthritis
    Khan, Sarah
    Mancini, Jacqueline
    Hopper, Charlene
    Resnick, Janet E.
    JOURNAL OF PEDIATRIC NURSING-NURSING CARE OF CHILDREN & FAMILIES, 2019, 48 : 49 - 54
  • [32] Methotrexate Hepatotoxicity in Children with Juvenile Idiopathic Arthritis: A Single-Center Study
    Yassin, Noha Adel
    Haroon, Mai
    Elhamshary, Azza
    CURRENT RHEUMATOLOGY REVIEWS, 2021, 17 (02) : 242 - 246
  • [33] Relationship Between Polymorphisms in Methotrexate Pathway Genes and Outcome of Methotrexate Treatment in a Cohort of 119 Patients with Juvenile Idiopathic Arthritis
    Avramovic, Mojca Zajc
    Dolzan, Vita
    Toplak, Natasa
    Accetto, Meta
    Lusa, Lara
    Avcin, Tadej
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (08) : 1216 - 1223
  • [34] Predictors of response to methotrexate in juvenile idiopathic arthritis
    Mohamed Albarouni
    Ingrid Becker
    Gerd Horneff
    Pediatric Rheumatology, 12
  • [35] Reasons for stopping methotrexate treatment in patients with juvenile idiopathic arthritis
    Ana Carolina Da Silva
    A Farias
    Nailu Sinicato
    R Veloso
    Roberto Marini
    Simone Appenzeller
    Pediatric Rheumatology, 12 (Suppl 1)
  • [36] Oral or Parenteral Methotrexate for the Treatment of Polyarticular Juvenile Idiopathic Arthritis
    Bakry, Reima
    Klein, Med A.
    Horneff, Gerd
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2022, 9 (04) : 197 - 205
  • [37] Meningococcal ACWY conjugate vaccine immunogenicity and safety in adolescents with juvenile idiopathic arthritis and inflammatory bowel disease: A prospective observational cohort study
    Ohm, Milou
    van Straalen, Joeri W.
    Zijlstra, Marieke
    de Joode-Smink, Gerrie
    Sellies, Anne Jasmijn
    Swart, Joost F.
    Vastert, Sebastiaan J.
    Montfrans, Joris M. van
    Bartels, Marije
    van Royen-Kerkhof, Annet
    Wildenbeest, Joanne G.
    Lindemans, Caroline A.
    Wolters, Victorien M.
    Wennink, Roos A. W.
    de Boer, Joke H.
    Knol, Mirjam J.
    Heijstek, Marloes W.
    Sanders, Elisabeth A. M.
    Verduyn-Lunel, Frans M.
    Berbers, Guy A. M.
    Wulffraat, Nico M.
    Jansen, Marc H. A.
    VACCINE, 2023, 41 (25) : 3782 - 3789
  • [38] Genetic variants influencing response to methotrexate in juvenile idiopathic arthritis and rheumatoid arthritis
    Ranganathan, Prabha
    RHEUMATOLOGY INTERNATIONAL, 2016, 36 (01) : 53 - 54
  • [39] Fibrosis indexes in adolescents with juvenile idiopathic arthritis treated with methotrexate
    Parkhomenko, Liudmyla
    Strashok, Larysa
    Pavlov, Sergey
    Pavlova, Olga
    PEDIATRIA I MEDYCYNA RODZINNA-PAEDIATRICS AND FAMILY MEDICINE, 2021, 17 (01): : 52 - 56
  • [40] Responses of patients with juvenile idiopathic arthritis to methotrexate: a genomic outlook
    Selvestrel, Davide
    Lucafo, Marianna
    Pugnetti, Letizia
    Pagarin, Sofia
    Moressa, Valentina
    Pastore, Serena
    Taddio, Andrea
    Stocco, Gabriele
    Decorti, Giuliana
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (10) : 1131 - 1142
12345